Fungal peritonitis in patients receiving peritoneal dialysis

experience with 11 patients and review of the literature.

E. S. Eisenberg, Ira Leviton, R. Soeiro

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Despite progress in decreasing the incidence of and improving the therapy for bacterial peritonitis in patients receiving peritoneal dialysis, fungal peritonitis has emerged as a relatively common infection. Hospitalization, recent prior episodes of peritonitis, and antibacterial therapy appear to predispose patients to this infection. Clinically, fungal peritonitis cannot be differentiated from bacterial peritonitis except by gram stain and culture of the dialysate. The most commonly made serious error is the failure to initiate appropriate therapy quickly enough on the basis of these diagnostic parameters. For patients who no longer require dialysis, those for whom a change to hemodialysis is preferred, and those with concomitant life-threatening illness, the recommended therapy for fungal peritonitis is removal of the dialysis catheter and the institution of therapy with systemic antifungal agents. For patients who are hemodynamically and metabolically stable and for whom continued peritoneal dialysis is desirable, a trial of antifungal chemotherapy before removal of the catheter may be indicated.

Original languageEnglish (US)
Pages (from-to)309-321
Number of pages13
JournalReviews of Infectious Diseases
Volume8
Issue number3
StatePublished - May 1986

Fingerprint

Peritoneal Dialysis
Peritonitis
Dialysis
Catheters
Therapeutics
Antifungal Agents
Dialysis Solutions
Infection
Renal Dialysis
Hospitalization
Drug Therapy
Incidence

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Fungal peritonitis in patients receiving peritoneal dialysis : experience with 11 patients and review of the literature. / Eisenberg, E. S.; Leviton, Ira; Soeiro, R.

In: Reviews of Infectious Diseases, Vol. 8, No. 3, 05.1986, p. 309-321.

Research output: Contribution to journalArticle

@article{13f806784a9a496d8168ab702b834f65,
title = "Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature.",
abstract = "Despite progress in decreasing the incidence of and improving the therapy for bacterial peritonitis in patients receiving peritoneal dialysis, fungal peritonitis has emerged as a relatively common infection. Hospitalization, recent prior episodes of peritonitis, and antibacterial therapy appear to predispose patients to this infection. Clinically, fungal peritonitis cannot be differentiated from bacterial peritonitis except by gram stain and culture of the dialysate. The most commonly made serious error is the failure to initiate appropriate therapy quickly enough on the basis of these diagnostic parameters. For patients who no longer require dialysis, those for whom a change to hemodialysis is preferred, and those with concomitant life-threatening illness, the recommended therapy for fungal peritonitis is removal of the dialysis catheter and the institution of therapy with systemic antifungal agents. For patients who are hemodynamically and metabolically stable and for whom continued peritoneal dialysis is desirable, a trial of antifungal chemotherapy before removal of the catheter may be indicated.",
author = "Eisenberg, {E. S.} and Ira Leviton and R. Soeiro",
year = "1986",
month = "5",
language = "English (US)",
volume = "8",
pages = "309--321",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Fungal peritonitis in patients receiving peritoneal dialysis

T2 - experience with 11 patients and review of the literature.

AU - Eisenberg, E. S.

AU - Leviton, Ira

AU - Soeiro, R.

PY - 1986/5

Y1 - 1986/5

N2 - Despite progress in decreasing the incidence of and improving the therapy for bacterial peritonitis in patients receiving peritoneal dialysis, fungal peritonitis has emerged as a relatively common infection. Hospitalization, recent prior episodes of peritonitis, and antibacterial therapy appear to predispose patients to this infection. Clinically, fungal peritonitis cannot be differentiated from bacterial peritonitis except by gram stain and culture of the dialysate. The most commonly made serious error is the failure to initiate appropriate therapy quickly enough on the basis of these diagnostic parameters. For patients who no longer require dialysis, those for whom a change to hemodialysis is preferred, and those with concomitant life-threatening illness, the recommended therapy for fungal peritonitis is removal of the dialysis catheter and the institution of therapy with systemic antifungal agents. For patients who are hemodynamically and metabolically stable and for whom continued peritoneal dialysis is desirable, a trial of antifungal chemotherapy before removal of the catheter may be indicated.

AB - Despite progress in decreasing the incidence of and improving the therapy for bacterial peritonitis in patients receiving peritoneal dialysis, fungal peritonitis has emerged as a relatively common infection. Hospitalization, recent prior episodes of peritonitis, and antibacterial therapy appear to predispose patients to this infection. Clinically, fungal peritonitis cannot be differentiated from bacterial peritonitis except by gram stain and culture of the dialysate. The most commonly made serious error is the failure to initiate appropriate therapy quickly enough on the basis of these diagnostic parameters. For patients who no longer require dialysis, those for whom a change to hemodialysis is preferred, and those with concomitant life-threatening illness, the recommended therapy for fungal peritonitis is removal of the dialysis catheter and the institution of therapy with systemic antifungal agents. For patients who are hemodynamically and metabolically stable and for whom continued peritoneal dialysis is desirable, a trial of antifungal chemotherapy before removal of the catheter may be indicated.

UR - http://www.scopus.com/inward/record.url?scp=0022712452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022712452&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 309

EP - 321

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 3

ER -